Ignite Creation Date:
2024-05-06 @ 7:36 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06078592
Status:
COMPLETED
Last Update Posted:
2023-10-12
First Post:
2023-07-19
Brief Title:
Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive
Sponsor:
CHA University
Organization:
CHA University
Study Overview
Official Title:
Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN- PLUS Eye Drops and COMBIGAN Eye Drops in Glaucoma or Ocular Hypertensive Patients
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BCT
Brief Summary:
Comparison of Efficacy and Ocular Surface Disease Assessment between BRIDIN-plus Eye drops and Combigan Eye drops in Glaucoma or Ocular Hypertensive Patients Phase 4 Parallel Group Design Investigator-blind Active-control Randomized Multi-center Trial
Detailed Description:
The purpose of this clinical trial is to prove lower negative effects on ocular surface disease and higher patient compliance of a single-use formula BRIDIN-PLUS eye drops group comparing to a multi-use formula COMBIGAN eye drops after 12 weeks of administration to glaucoma or ocular hypertensive patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None